RICE HALL JAMES & ASSOCIATES, LLC AMICUS THERAPEUTICS INC holdings history
AMICUS THERAPEUTICS INC · CUSIP 03152W109 · CIK 1230765
As of 2026-03-31, RICE HALL JAMES & ASSOCIATES, LLC reported 770.71K AMICUS THERAPEUTICS INC (shares), valued at $11.14M, or 0.62% of its reported non-derivative portfolio. Filed 2026-05-15.
Verify history & sources →Shares decreased 78.04%; reported value decreased 77.70%, and weight changed -2.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.
Left: % · Right: Shares · Independently scaled axes
Exact data and methodology
Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.
| Quarter | Weight | Quantity | Source |
|---|---|---|---|
| Q2 2026 | Not reported | Not reported | — |
| Q1 2026 | 0.62% | 770,711 | SEC filing ↗Filed May 15, 2026 |
| Q4 2025 | 2.75% | 3,509,571 | SEC filing ↗Filed Feb 17, 2026 |
| Q3 2025 | 1.48% | 3,434,717 | SEC filing ↗Filed Oct 16, 2025 |
| Q2 2025 | 0.85% | 2,760,314 | SEC filing ↗Filed Aug 11, 2025 |
| Q1 2025 | 0.96% | 2,010,104 | SEC filing ↗Filed May 1, 2025 |
| Q4 2024 | 0.71% | 1,371,080 | SEC filing ↗Filed Jan 31, 2025 |
| Q3 2024 | 0.56% | 972,138 | SEC filing ↗Filed Oct 28, 2024 |
| Q2 2024 | 0.58% | 972,284 | SEC filing ↗Filed Aug 7, 2024Combination report |
| Q1 2024 | 0.69% | 1,028,569 | SEC filing ↗Filed Apr 23, 2024Combination report |
| Q4 2023 | 0.88% | 1,065,965 | SEC filing ↗Filed Feb 9, 2024Combination report |
History & evidence by quarter
| Quarter | Weight | Quantity | Value | Change explained | Source |
|---|---|---|---|---|---|
| Q4 2023 | 0.88% | 1,065,965 | $15.13M | The prior quarter is outside the free window. Sign in for the comparison. | SEC filing ↗ Filed Feb 9, 2024 |
| Q1 2024 | 0.69% | 1,028,569 | $12.12M | Shares decreased 3.51%; reported value decreased 19.90%, and weight changed -0.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Apr 23, 2024 |
| Q2 2024 | 0.58% | 972,284 | $9.65M | Shares decreased 5.47%; reported value decreased 20.40%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Aug 7, 2024 |
| Q3 2024 | 0.56% | 972,138 | $10.38M | Shares decreased 0.02%; reported value increased 7.65%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Oct 28, 2024 |
| Q4 2024 | 0.71% | 1,371,080 | $12.92M | Shares increased 41.04%; reported value increased 24.40%, and weight changed +0.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Jan 31, 2025 |
| Q1 2025 | 0.96% | 2,010,104 | $16.40M | Shares increased 46.61%; reported value increased 27.00%, and weight changed +0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed May 1, 2025 |
| Q2 2025 | 0.85% | 2,760,314 | $15.82M | Shares increased 37.32%; reported value decreased 3.57%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Aug 11, 2025 |
| Q3 2025 | 1.48% | 3,434,717 | $27.07M | Shares increased 24.43%; reported value increased 71.12%, and weight changed +0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Oct 16, 2025 |
| Q4 2025 | 2.75% | 3,509,571 | $49.98M | Shares increased 2.18%; reported value increased 84.65%, and weight changed +1.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed Feb 17, 2026 |
| Q1 2026 | 0.62% | 770,711 | $11.14M | Shares decreased 78.04%; reported value decreased 77.70%, and weight changed -2.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds. | SEC filing ↗ Filed May 15, 2026 |
| Q2 2026 | Not reported | — | — | This security is absent from this quarter's filing; a missing record is not treated as zero holdings. | — |
Take these holdings further.
This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1230765","quarter":"2026Q2","cusip":"03152W109"}
get_institutional_manager_history
{"cik":"1230765","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.